The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women
Open accessAbstract
Women with polycystic ovary syndrome (PCOS) are insulin resistant, have insulin secretory defects, and are at high risk for glucose intolerance. We performed this study to determine the prevalence of glucose intolerance and parameters associated with risk for this in PCOS women. Two-hundred and fifty-four PCOS women, aged 14-44 yr, were prospectively evaluated at 2 centers, 1 urban and ethnically diverse (n = 110) and 1 rural and ethnically homogeneous (n = 144). The rural PCOS women were compared to 80 control women of similar weight, ethnicity, and age. A 75-g oral glucose challenge was administered after a 3-day 300-g carbohydrate diet and an overnight fast with 0 and 2 h blood samples for glucose levels. Diabetes was categorized according to WHO criteria. The prevalence of glucose intolerance was 31.1% impaired glucose intolerance (IGT) and 7.5% diabetes. In nonobese PCOS women (body mass index, <27 kg/m2), 10.3% IGT and 1.5% diabetes were found. The prevalence of glucose intolerance was significantly higher in PCOS vs. control women (chi2 = 7.0; P = 0.01; odds ratio = 2.76; 95% confidence interval = 1.23-6.57). Variables most associated with postchallenge glucose levels were fasting glucose levels (P < 0.0001), PCOS status (P = 0.002), waist/hip ratio (P = 0.01), and body mass index (P = 0.021). The American Diabetes Association criteria applied to fasting glucose significantly underdiagnosed diabetes compared to the WHO criteria (3.2% vs. 7.5%; chi2 = 4.7; P = 0.046; odds ratio = 2.48; 95% confidence interval = 1.01-6.69). We conclude that 1) PCOS women are at significantly increased risk for IGT and type 2 diabetes mellitus at all weights and at a young age; 2) these prevalence rates are similar in 2 different populations of PCOS women, suggesting that PCOS may be a more important risk factor than ethnicity or race for glucose intolerance in young women; and 3) the American Diabetes Association diabetes diagnostic criteria failed to detect a significant number of PCOS women with diabetes by postchallenge glucose values.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As such, women with PCOS exhibit increased risk of impaired glucose tolerance and T2DM regardless of weight and age [20].”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [20]
In the citing paper
“Approximately 50–70% of women with PCOS have IR and hyperinsulinaemia [128], whereas many also present evidence of glucose intolerance [20].”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [20]
In the citing paper
“In women with PCOS, dysglycemia typically consists of impaired glucose tolerance [12], its prevalence being of almost 30% in both adult women [13] and affected adolescents [14].”
From From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management (2020) · cites this paper as [12]
In the citing paper
“PCOS patients commonly have metabolic complications, such as type 2 diabetes, insulin resistance (IR), and adipose tissue dysfunction (7–9).”
From Circulating Adipokine Levels in Nonobese Women with Polycystic Ovary Syndrome and in Nonobese Control Women: A Systematic Review and Meta-Analysis (2021) · cites this paper as [7]
In the citing paper
“However, women with PCOS generally have hyperandrogenism and lower SHBG [52] and differences at the end of the intervention are again likely related to baseline differences.”
From Weight management interventions in women with and without PCOS: a systematic review (2017) · cites this paper as [52]
In the citing paper
“However, women with PCOS generally have hyperandrogenism and lower SHBG [52] and differences at the end of the intervention are again likely related to baseline differences.”
From Weight management interventions in women with and without PCOS: a systematic review (2017) · cites this paper as [52]
In the citing paper
“In PCOS, other novel CVD risk factors, premature cardiovascular dysfunction and subclinical CVD 29,30,83 have been noted and are related to IR and obesity. 84-89”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [85]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 801–900 of 1,388
The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome
Sivanandy, M. S., & Ha, S. K. (2023) · Diagnostics · doi:10.3390/diagnostics13050907 · Cited by 35
Circulating miRNAs in Women with Polycystic Ovary Syndrome: A Longitudinal Cohort Study
Udesen, P. B., Sørensen, A. E., Svendsen, R. P., Frisk, N. L. S., Hess, A. L., Aziz, M., Wissing, M. L., Englund, A. L. M., & Dalgaard, L. T. (2023) · Cells · doi:10.3390/cells12070983 · Cited by 26
Wilson, J. L., Chen, W., Dissen, G. A., Ojeda, S. R., Cowley, M. A., Garcia‐Rudaz, C., & Enriori, P. J. (2014) · Endocrinology · doi:10.1210/en.2014-1368 · Cited by 27
Evaluating reported candidate gene associations with polycystic ovary syndrome
Pau, C. T., Saxena, R., & Welt, C. K. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.12.033 · Cited by 26
Prevalencia de hiperandrogenismo y síndrome de ovario poliquístico en transexuales de mujer a hombre
Becerra-Fernández, A., López, G. P., Román, M. M., Martin-Lazaro, J. F., Pérez, M. J. L., Araque, N. A., Rodríguez-Molina, J. M., Sertucha, M. C. B., & Vilas, M. V. A. (2014) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2014.01.010 · Cited by 27
Seow, K., Hwang, J., Wang, P.-Y., Ho, L. T., & Juan, C. (2011) · Human Reproduction · doi:10.1093/humrep/der267 · Cited by 27
Li, L., Zhu, J., Ye, F., Duan, Z., Zhou, J., Huang, Z., & Wang, L. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3507 · Cited by 27
Prevalence of abnormalities of glucose metabolism in patients with polycystic ovary syndrome
Barcellos, C. R. G., Rocha, M. P., Hayashida, S. A. Y., Nery, M., & Marcondes, J. A. M. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000400015 · Cited by 27
Clomiphene Versus Metformin for Ovulation Induction in Polycystic Ovary Syndrome: The Winner Is ….
Barbieri, R. L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1393 · Cited by 29
Chinese herbal medicine for subfertile women with polycystic ovarian syndrome
Zhang, J., Li, T., Zhou, L., Tang, L., Xu, L., Wu, T., & Lim, D. C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007535.pub2 · Cited by 26
Berbrier, D. E., Leone, C. A., Adler, T. E., Bender, J. R., Taylor, H. S., Stachenfeld, N. S., & Usselman, C. W. (2023) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00583.2022 · Cited by 27
Koiou, E., Τζιόμαλος, Κ., Katsikis, I., Kalaitzakis, E., Kandaraki, E., Tsourdi, E. A., Delkos, D., Papadakis, E. P., & Panidis, D. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0144 · Cited by 27
Song, D. K., Lee, H., Sung, Y., & Oh, J. Y. (2016) · Yonsei Medical Journal · doi:10.3349/ymj.2016.57.6.1404 · Cited by 27
Jensterle, M., Goričar, K., & Janež, A. (2017) · Endocrine Research · doi:10.1080/07435800.2017.1294602 · Cited by 27
Hambly, R., Kearney, N., Hughes, R., Fletcher, J. M., & Kirby, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086969 · Cited by 31
Veltman-Verhulst, S. M., Goverde, A. J., van Haeften, T. W., & Fauser, B. C. J. M. (2013) · Human Reproduction · doi:10.1093/humrep/det226 · Cited by 25
Mohsen, I. A., ElKattan, E. A., Nabil, H., & Khattab, S. (2012) · Journal of Clinical Ultrasound · doi:10.1002/jcu.22006 · Cited by 26
Surgical management of metabolic dysfunction in PCOS
Escobar-Morreale, H. F. (2011) · Steroids · doi:10.1016/j.steroids.2011.12.004 · Cited by 26
Joham, A. E., Teede, H. J., Hutchison, S. K., Stepto, N. K., Harrison, C. L., Strauss, B. J., Paul, E. M., & Watt, M. J. (2012) · Obesity · doi:10.1038/oby.2012.135 · Cited by 26
Insulin Resistance and Adolescent Girls with Polycystic Ovary Syndrome
Bhattacharya, S. M., & Ghosh, M. (2009) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2009.10.004 · Cited by 24
Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes
Saxena, R., & Welt, C. K. (2012) · Acta Diabetologica · doi:10.1007/s00592-012-0383-4 · Cited by 27
Yasmin, E., Balen, A. H., & Barth, J. H. (2012) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2012.09.025 · Cited by 27
Treatment of the adolescent patient with polycystic ovary syndrome
Pfeifer, S. M., & Dayal, M. B. (2003) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(03)00028-7 · Cited by 28
Coronary Heart Disease in Women With Diabetes
Koerbel, G. L., & Korytkowski, M. (2003) · Diabetes Spectrum · doi:10.2337/diaspect.16.3.148 · Cited by 26
Glitazones and the management of insulin resistance: what they do and how might they be used
EINHORN, D. F., Aroda, V. R., & Henry, R. R. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.04.003 · Cited by 26
Şahin, S., Eroğlu, M., Selcuk, S., Turkgeldi, L. S., Kozalı, Ş., Davutoğlu, S., & Muhçu, M. (2014) · PubMed · Cited by 26
Serum visfatin in Asian women with polycystic ovary syndrome
Jongwutiwes, T., Lertvikool, S., Leelaphiwat, S., Rattanasiri, S., Jultanmas, R., & Weerakiet, S. (2009) · Gynecological Endocrinology · doi:10.1080/09513590903015478 · Cited by 26
Yildir, I. C., Kutlutürk, F., Taşlıyurt, T., Yelken, B., Acu, B., Beyhan, M., Erkorkmaz, Ü., & Yılmaz, A. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.730573 · Cited by 26
Pau, C. T., Keefe, C. C., & Welt, C. K. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.788634 · Cited by 26
Saghafi‐Asl, M., Pirouzpanah, S., Ebrahimi-Mameghani, M., Asghari-Jafarabad4, M., Aliashrafi, S., & Sadein, B. (2013) · Europe PMC (PubMed Central) · doi:10.5681/hpp.2013.024 · Cited by 33
In VitroFertilisation: Perinatal Risks and Early Childhood Outcomes
Document, J. R. (2012) · Human Fertility · doi:10.3109/14647273.2012.663571 · Cited by 26
Kerem, N. C., Guttmann, H., & Hochberg, Z. (2001) · Hormone Research in Paediatrics · doi:10.1159/000050017 · Cited by 26
Yılmaz, M., Ergün, M. A., Karakoç, A., Yurtçu, E., Yetkin, İ., Ayvaz, G., Çakır, N., & Arslan, M. (2005) · Gynecological Endocrinology · doi:10.1080/09513590500231593 · Cited by 26
Dhesi, A. S., Murtough, K. L., Lim, J. K., Schulkin, J. A., McGovern, P. G., Power, M. L., & Morelli, S. S. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.07.043 · Cited by 25
Aggarwal, K., Agrawal, H., & Jain, A. (2019) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_559_18 · Cited by 25
Polycystic ovary syndrome: a review for primary providers
Buccola, J. M., & Reynolds, E. E. (2003) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(03)00089-7 · Cited by 25
Prevalence of elevated glycated hemoglobin in women with polycystic ovary syndrome
Kim, J., Choi, Y. M., Cho, Y. M., Jung, H. S., Chae, S. J., Hwang, K. R., Hwang, S.-S., Ku, S., Kim, S. H., Kim, J. G., et al. (2012) · Human Reproduction · doi:10.1093/humrep/des039 · Cited by 25
Insulin Resistant States and Insulin Signaling
Vollenweider, P. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.173 · Cited by 26
Insulin Resistance in Adolescents with Menstrual Irregularities
Fernandes, A. R., Silva, A. C. J. D. S. R. E., Romão, G. S., Pata, M. C., & dos Reis, R. M. (2005) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2005.05.006 · Cited by 25
Kiconco, S., Tay, C. T., Rassie, K. L., Azziz, R., Teede, H. J., & Joham, A. E. (2022) · Clinical Endocrinology · doi:10.1111/cen.14647 · Cited by 25
Zheng, R., Qing, P., Han, M., Song, J., Hu, M., Ma, H., & Li, J. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5555028 · Cited by 27
Prevalence of polycystic ovary syndrome in reproductive-aged women with type 2 diabetes
Amini, M., Horri, N., Farmani, M., Haghighi, S., Sattari, G., Pornaghshband, Z., & Aminorroaya, A. (2008) · Gynecological Endocrinology · doi:10.1080/09513590802306143 · Cited by 25
The Polycystic Ovary Syndrome: Current Concepts On Pathogenesis And Clinical Care
Azziz, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-69248-7 · Cited by 25
Wang, W., Guo, Y. C., Zhang, X., & Zheng, J. (2018) · Clinical Endocrinology · doi:10.1111/cen.13805 · Cited by 24
Güleken, Z., Bulut, H., Bulut, B., Paja, W., Orzechowska, B., Parlińska‐Wojtan, M., & Depciuch, J. (2022) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2022.121029 · Cited by 25
Chinese herbal medicine for subfertile women with polycystic ovarian syndrome
Zhou, K., Zhang, J., Xu, L., & Lim, C. E. D. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007535.pub4 · Cited by 26
Freeman, R., Pollack, R. M., & Rosenbloom, E. (2010) · Endocrine Practice · doi:10.4158/ep09330.or · Cited by 24
Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
Gateva, A., & Kamenov, Z. A. (2012) · Obstetrics and Gynecology International · doi:10.1155/2012/306347 · Cited by 23
Long Menstrual Cycle Is Associated with Type 2 Diabetes Mellitus in Korean Women
Shim, U., Oh, J.-Y., Lee, H. J., Hong, Y. S., & Sung, Y. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.4.384 · Cited by 25
Normalization of hyperinsulinemia by chronic opioid receptor blockade in hyperandrogenemic women
Hadžiomerović, D., Rabenbauer, B., & Wildt, L. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.01.039 · Cited by 24
Prognostic factors for ovulatory response with clomiphene citrate in polycystic ovary syndrome
Kurabayashi, T., Suzuki, M., Fujita, K., Murakawa, H., Hasegawa, I., & Tanaka, K. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.11.005 · Cited by 24
Predictors of abnormal glucose metabolism in women with polycystic ovary syndrome
Möhlig, M., Spranger, J., Ristow, M., Pfeiffer, A. F. H., Schill, T., Schlösser, H. W., Moltz, L., Brabant, G. E., & Schöfl, C. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02095 · Cited by 24
Polycystic ovary Syndrome in Adolescents: Pitfalls in Diagnosis and Management
Kostopoulou, E., Anagnostis, P. G., Bosdou, J. Κ., Spiliotis, B. E., & Goulis, D. G. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00388-9 · Cited by 24
Management of Polycystic Ovary Syndrome in India
Malik, S., Jain, K., Talwar, P., Prasad, S., Dhorepatil, B., Devi, G., Khurana, A., Bhatia, V., Chandiok, N., Kriplani, A., et al. (2014) · Fertility Science and Research · doi:10.4103/2394-4285.146798 · Cited by 26
Seow, K., Juan, C., Wang, P., Ho, L., & Hwang, J. (2012) · Gynecologic and Obstetric Investigation · doi:10.1159/000334175 · Cited by 24
Polycystic Ovary Syndrome and Chronic Inflammation: Pharmacotherapeutic Implications
Sirmans, S. M., Weidman-Evans, E., Everton, V., & Thompson, D. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1q514 · Cited by 24
Kyrkou, G. A., Trakakis, E., Attilakos, A., Panagopoulos, P., Chrelias, C. G., Papadimitriou, A., Vaggopoulos, V., Alexiou, E., Mastorakos, G., Lykeridou, A., et al. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3964-y · Cited by 24
The Safety of Postmenopausal Testosterone Therapy
Maclaran, K., & Panay, N. (2012) · Women s Health · doi:10.2217/whe.12.11 · Cited by 23
Yalamanchi, S. K., Sam, S., Cardenas, M. O., Holaday, L. W., Urbanek, M., & Dunaif, A. E. (2012) · Obesity · doi:10.1038/oby.2011.400 · Cited by 23
Self-citationBranavan, U., Wijesundera, S., Chandrasekaran, V., Arambepola, C., & Wijeyaratne, C. N. (2020) · BMC Medical Genetics · doi:10.1186/s12881-020-0961-1 · Cited by 23
Przybycień, P., Gąsior‐Perczak, D., & Placha, W. (2022) · Cells · doi:10.3390/cells11162569 · Cited by 26
Raja-Khan, N. T., Agito, K., Shah, J., Stetter, C., Gustafson, T. S., Socolow, H., Kunselman, A. R., Reibel, D. K., & Legro, R. S. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.01.021 · Cited by 28
Self-citationPremicroalbuminuria in Women with Polycystic Ovary Syndrome: A Metabolic Risk Marker
Patel, A. A., Bloomgarden, Z. T., & Futterweit, W. (2008) · Endocrine Practice · doi:10.4158/ep.14.2.193 · Cited by 23
Assessment of glucose intolerance and insulin sensitivity in polycystic ovary syndrome.
Yıldız, B., & Gedik, O. (2004) · Reproductive Biomedicine Online · doi:10.1016/s1472-6483(10)61645-8 · Cited by 27
Davinelli, S., Nicolosi, D., Cesare, C. D., Scapagnini, G., & Marco, R. D. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9040987 · Cited by 23
Koçak, İ., & Üstün, C. (2006) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2006.00401.x · Cited by 23
RetractedPremature Adrenarche Leads to Polycystic Ovary Syndrome?
Κousta, E. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1365.013 · Cited by 25
Gencer, M., Gazı, E., Hacıvelioğlu, S., Binnetoğlu, E., Barutçu, A., Türkön, H., Temız, A., Altun, B., Vural, A., Cevızcı, S., et al. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.07.032 · Cited by 23
Metabolic syndrome and other factors associated with increased risk of diabetes
Streja, D. A. (2004) · Clinical cornerstone · doi:10.1016/s1098-3597(04)80094-2 · Cited by 23
The polycystic ovary syndrome: treatment with insulin sensitizing agents
Iuorno, M. J., & Nestler, J. E. (1999) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.1999.00026.x · Cited by 23
Insulin treatment increases myocardial ceramide accumulation and disrupts cardiometabolic function
Hodson, A. E., Tippetts, T. S., & Bikman, B. T. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0316-y · Cited by 25
CHRISTOPOULOS, P. F., Mastorakos, G. P., Gazouli, M., Deligeoroglou, E., Katsikis, I., Diamanti‐Kandarakis, E., Panidis, D., & Creatsas, G. C. (2010) · Gynecological Endocrinology · doi:10.3109/09513591003649823 · Cited by 23
Continuous Glucose Monitoring During Pregnancy in Women With Polycystic Ovary Syndrome
Dmitrovic, R., Katcher, H. I., Kunselman, A. R., & Legro, R. S. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31822c887f · Cited by 23
Self-citationClinical characteristics in Taiwanese women with polycystic ovary syndrome
Hsu, M.-I. (2015) · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine · doi:10.5653/cerm.2015.42.3.86 · Cited by 23
Polycystic Ovary Syndrome: Features, Diagnostic Criteria and Treatments
Gullo, G. (2014) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000136 · Cited by 25
Qu, Q., Zhao, D., Zhang, F., Bao, H., & Yang, Q. (2017) · Journal of International Medical Research · doi:10.1177/0300060516680441 · Cited by 23
Sawathiparnich, P., Weerakulwattana, L., Santiprabhob, J., & Likitmaskul, S. (2005) · PubMed · Cited by 23
Evaluation and Management of Infertility in Women: The Internists' Role
Rosene‐Montella, K., Keely, E., Laifer, S. A., & Lee, R. V. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-12-200006200-00008 · Cited by 23
Maffazioli, G. D. N., Lopes, C. P., Heinrich‐Oliveira, V., Løbo, R. A., Hayashida, S. A. Y., Soares, J. M., Maciel, G. A. R., & Baracat, E. C. (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13374 · Cited by 23
The Classification of Diabetes Mellitus: A Conceptual Framework
Ize-Ludlow, D., & Sperling, M. A. (2005) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2005.07.001 · Cited by 22
Costa, L. O. B. F., dos Santos, M. P., de Oliveira, M., & Viana, A. D. O. R. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.04.005 · Cited by 22
Zangeneh, F. Z., Mohammadi, A., Ejtemaeimehr, S., Naghizadeh, M. M., & Aminee, F. (2010) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-010-1776-7 · Cited by 23
Genetic overlap between polycystic ovary syndrome and bipolar disorder: The endophenotype hypothesis
Jiang, B., Kenna, H. A., & Rasgon, N. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.12.056 · Cited by 22
Tuğrul, S., Kutlu, T., Pekin, O., Bağlam, E., Kiyak, H. A., & Oral, Ö. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.07.1326 · Cited by 22
Physiology and Pathology of the Female Reproductive Axis
Bulun, S. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00017-4 · Cited by 22
The Management of Polycystic Ovary Syndrome
Bruni, V., Dei, M., Pontello, V., & VANGELISTI, P. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.034 · Cited by 22
Clinical and metabolic findings in adolescent females with hyperandrogenism
Huppert, J. S., Chiodi, M., & Hillard, P. J. A. (2004) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2004.01.005 · Cited by 22
Rocha, M. P., Maranhão, R. C., Seydell, T. M., Barcellos, C. R. G., Baracat, E. C., Hayashida, S. A. Y., Bydlowski, S. P., & Marcondes, J. A. M. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.12.044 · Cited by 22
Metabolic effects of polycystic ovary syndrome in adolescents
Han, Y., Kim, H. S., Lee, H.-J., Oh, J.-Y., & Sung, Y.-A. (2015) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2015.20.3.136 · Cited by 22
Liao, W., Huang, J., Lee, M.-T., Yang, Y., & Wu, C.-C. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i3.240 · Cited by 22
Cannarella, R., Condorelli, R. A., Dall’Oglio, F., Vignera, S. L., Mongioì, L. M., Micali, G., & Calogero, A. E. (2020) · International Journal of Endocrinology · doi:10.1155/2020/1942126 · Cited by 22
Review: Obesity and cardiometabolic syndrome in children
Velasquez‐Mieyer, P., Neira, C. P., Nieto-Martínez, R. E., & Cowan, P. A. (2007) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944707082800 · Cited by 21
Yang, H., Lee, H., Huang, W., Chen, M.-J., Chen, S. C., & Hsu, Y. (2017) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-017-0894-8 · Cited by 23
Shamdeen, M. Y., & Saber, M. (2005) · TSpace (University of Toronto) · Cited by 22
Salem, A. B., Ajina, M., Suissi, M., Daher, H. S., Almawi, W. Y., & Mahjoub, T. (2013) · Gene · doi:10.1016/j.gene.2013.09.104 · Cited by 21
The polycystic ovary syndrome: the first 150 years of study
Adashi, E. Y., Cibula, D., Peterson, M., & Azziz, R. (2022) · F&S Reports · doi:10.1016/j.xfre.2022.12.002 · Cited by 27
Markopoulos, M. C., Valsamakis, G., Kouskouni, E. E., Boutsiadis, A., Papassotiriou, I., Creatsas, G. K., & Mastorakos, G. P. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0550 · Cited by 20
Yan, Y., Qiao, J., & Li, M. (2010) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-8-125 · Cited by 21
Testosterone in Women: Measurement and Therapeutic Use
Korkidakis, A., & Reid, R. L. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.01.006 · Cited by 21
Increased risk for diabetes mellitus in patients with carbon monoxide poisoning
Huang, C., Ho, C., Chen, Y., Lin, H.-J., Hsu, C.-C., Wang, J.-J., Su, S., & Guo, H. (2017) · Oncotarget · doi:10.18632/oncotarget.18887 · Cited by 21
Metadata
- Authors
- Legro, R. S.
- Affiliations
- Pennsylvania State University (US)
- ORCID
- Legro, R. S.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-01-01
- Volume
- 84
- Issue
- 1
- Pages
- 165-169
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2096126402
- Cited by
- 1,743
- References
- 0
- Citations by year
- 2026: 16 · 2025: 25 · 2024: 36 · 2023: 24 · 2022: 50 · 2021: 64 · 2020: 54 · 2019: 42 · 2018: 43 · 2017: 66 · 2016: 59 · 2015: 88 · 2014: 81 · 2013: 73 · 2012: 84
- FWCI
- 44.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040605)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K08 HD-O118, U54HD034449)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Keywords
- polycystic ovary syndrome, type 2 diabetes, impaired glucose tolerance, insulin resistance, insulin secretion, diabetes risk factors, prevalence, fasting blood glucose, waist-to-hip ratio, body mass index, ethnic differences, diagnostic criteria, underdiagnosis, oral glucose tolerance test, young women, obesity
- MeSH terms
- Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Humans, Insulin Resistance, Polycystic Ovary Syndrome, Prospective Studies, Risk, Body Mass Index, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
